1-10 of 10
breast adenocarcinoma
Close
Sort by
Journal Articles

Predictive Factors of Response and Survival of Lenalidomide and Rituximab As Initial Treatment of Follicular Lymphoma

Paolo Strati, MD, Ralph J. Johnson, PhD, Sheryl G Forbes, Loretta J. Nastoupil, MD MSc, Felipe Samaniego, MD, Eric Davis, MD, Michael R Green, PhD, Luis Fayad, MD, F. B. Hagemeister, MD, Jason R. Westin, MD, Michael L. Wang, MD, Sattva S Neelapu, MD, Nathan H Fowler, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1533.
https://doi.org/10.1182/blood-2019-129311
Published: 2019
Journal Articles

Targeted Therapy Of Acute Myeloid Leukemia By A CD117-Specific Aptamer-Drug-Conjugate

Nianxi Zhao, PhD, Sung-nan Pei, MD, Jianjun Qi, PhD, Pei Lin, MD, Youli Zu, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1446.
https://doi.org/10.1182/blood.V122.21.1446.1446
Published: 2013
Journal Articles

Cirmtuzumab Vedotin (UC-961ADC3), An Anti-ROR1-Monomethyl Auristatin E Antibody-Drug Conjugate, Is a Potential Treatment For ROR1-Positive Leukemia and Solid Tumors

Bing Cui, Ph.D, George F. Widhopf, II, PhD, Charles E. Prussak, Ph.D., Christina C.N. Wu, PhD, Anil Sadarangani, PhD, Suping Zhang, PhD, Fitzgerald Lao, Catriona HM Jamieson, MD, PhD, Dennis A. Carson, M.D, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1637.
https://doi.org/10.1182/blood.V122.21.1637.1637
Published: 2013
Journal Articles

Association of Renal Cell Carcinoma and B-Cell Hematological Malignancy

Rangaswamy Chintapatla, MD, Leticia Varella, M.D, Peter Wiernik, MD, Valerie Rusciano, R.N, Janice P. Dutcher, MD
Journal: Blood
Blood (2012) 120 (21): 5086.
https://doi.org/10.1182/blood.V120.21.5086.5086
Published: 2012
Journal Articles

EphB4 Expression and Biological Significance in Drug Resistance of Myeloid Leukemia

DU Qingfeng, Xu Lulu, Zhang Jinfang, Xu Na, Huang Bintao, Luo Xujing, Xiao Xiaozhen, Liu Xiaoli, MD
Journal: Blood
Blood (2011) 118 (21): 4725.
https://doi.org/10.1182/blood.V118.21.4725.4725
Published: 2011
Journal Articles

Eltrombopag Decreases Proliferation of Ovarian, Lung and Breast Tumor Cell Lines.

Connie L. Erickson-Miller, Jennifer Kirchner, Kodandaram Pillarisetti, Lone Ottesen, Yasser Mostafa Kamel, Yuan Liu, Anne-Marie Martin, Conrad Messam
Journal: Blood
Blood (2009) 114 (22): 2409.
https://doi.org/10.1182/blood.V114.22.2409.2409
Published: 2009
Journal Articles

B Cell Depletion Reduces the Number and Function of T- Regulatory Cells and Enhances the Anti Tumor response

Tamar Tadmor, MD, Yu Zhang, MD, Robert Dunn, PHD, Seung-uon Shin, Hyung-Mee Cho, Joseph Rosenblatt, MD
Journal: Blood
Blood (2009) 114 (22): 3668.
https://doi.org/10.1182/blood.V114.22.3668.3668
Published: 2009
Journal Articles

Vascular endothelial growth factor-D transgenic mice show enhanced blood capillary density, improved postischemic muscle regeneration, and increased susceptibility to tumor formation

Anna-Mari Kärkkäinen, Antti Kotimaa, Jenni Huusko, Ivana Kholova, Suvi Elina Heinonen, Anna Stefanska, Marike Hinke Dijkstra, Hanna Purhonen, Eveliina Hämäläinen, Petri Ilmari Mäkinen, Mikko Petri Turunen, Seppo Ylä-Herttuala
Journal: Blood
Blood (2009) 113 (18): 4468–4475.
https://doi.org/10.1182/blood-2008-07-171108
Published: 2009
Journal Articles

Platelet PF-4 Is an Early Marker of Tumor Angiogenesis.

Giannoula L. Klement, MD, David Cervi, PhD, Tai-Tung Yip, PhD, Judah Folkman, MD, Joseph Italiano, PhD
Journal: Blood
Blood (2006) 108 (11): 1476.
https://doi.org/10.1182/blood.V108.11.1476.1476
Published: 2006
Journal Articles

Expression of rat complement control protein Crry on tumor cells inhibits rat natural killer cell–mediated cytotoxicity

Theresa A. Caragine, Masaki Imai, Alan B. Frey, Stephen Tomlinson
Journal: Blood
Blood (2002) 100 (9): 3304–3310.
https://doi.org/10.1182/blood.V100.9.3304
Published: 2002